Cushing's Syndrome I
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| SPI-62 as a Treatment for Adrenocorticotropic Hormone-dependent Cushing's Syndrome (NCT05307328) | Sparrow Pharmaceuticals | 2022-09-01 |
Track Cushing's Syndrome I automatically
Every clearance here is in the API, with alerts when new ones post.